Oral medroxyprogesterone acetate for the use of ovulation suppression in in-vitro fertilization: A cohort trial

To broadly assess the efficacy of medroxyprogesterone acetate (MPA) for ovulatory suppression during in vitro stimulation (IVF) when compared to gonadotropin releasing hormone (GnRH) antagonist cycles

Source: Fertility and Sterility - January 20, 2024 Category: Reproduction Medicine Authors: Annalyn M. Welp, Chris D. Williams, Laura P. Smith, Scott Purcell, Linnea R. Goodman Tags: Assisted reproduction Source Type: research